Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes

BACKGROUND: Identification of novel genetic risk factors is imperative for a better understanding of B lymphomagenesis and for the development of novel therapeutic strategies. TRAF3, a critical regulator of B cell survival, was recently recognized as a tumor suppressor gene in B lymphocytes. The pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Shanique KE, Baron, Jacqueline, Moore, Carissa R, Liu, Yan, Perlman, David H, Hart, Ronald P, Xie, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172902/
https://www.ncbi.nlm.nih.gov/pubmed/25200342
http://dx.doi.org/10.1186/s13045-014-0056-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172902/
https://www.ncbi.nlm.nih.gov/pubmed/25200342
http://dx.doi.org/10.1186/s13045-014-0056-6

Ejemplares similares